S. The top 10 holdings account for about 10. 3. It has a total of 153 holdings. 06 as the 52 week high point — that compares with a last trade of $102. Company specialized in: Holding Companies. 01 to $0. 1% vs 0. 7% of assets. com) ReturnsXBI's top 10 holdings account for about 10. Top 10 Holdings. Free ratings, analyses, holdings, benchmarks, quotes, and news. Share class size. The ETF has a beta of 1. XBI holdings. 60%. View Holdings As of 09/30/2023. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. ($423. Implied XBI Analyst Target Price: $135. In that past 52-week period, it has traded between $62. , and Amgen Inc. If Moderna's share price. Both FBT and XBI are ETFs. And, again, it is in the top 15 holdings by weighting of the. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. Its top 10 holdings account for approximately 16. The ETF has lost about -12. AMGN. 1. S&P Select Industry Indices are designed to measure the performance of narrow GICS® sub-industries. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. View complete XLP exchange traded fund holdings for better informed ETF trading. The fund’s NAV was $81. 7657M. The firm has a market cap of $5. Its top 10 holdings account for approximately 16. m. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. XBI Holdings 5 Beaten-Down ETFs to Buy Now. MRTX. IBB has a higher 5-year return than XBI (0. Stock Analysis Chart Headlines Holdings Ownership Ratings. LABU has a lower 5-year return than XBI (-46. Below is the comparison between ARKG and XBI. Visitors trend 2W 10W 9M. Meanwhile, XBI equal weights its holdings. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. 94 per share, with $107. **Close price adjusted for splits and dividend and/or capital gain distributions. The gross expense ratio is the fund’s total annual operating expenses ratio. 5% on the day. Start Free Trial. Growth of Hypothetical $10,000. Seagen Inc Ordinary Shares. 16bn USD. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. View the latest ETF prices and news for better ETF investing. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. Analysis of these related ETFs and how they are trading may provide insight to this commodity. Learn everything about SPDR S&P Biotech ETF (XBI). Its price to cash flow multiples is about 13. XBI holdings. LABU has a higher expense ratio than XBI (1. WIX. Also includes news, ETF details and other investing information. 15 per share, with $174. It is gross of any fee waivers or expense reimbursements. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. 57 billion. Follow. Brazil. 71. Stocks. There is no guarantee the funds will achieve their stated investment objectives. Monday's ETF Movers: XBI, QCLN. Also includes news, ETF details and other investing information. For investors that want to rely on modern portfolio theory rather than assessing biotechnology companies, this is a solid option. 9%. 50 -0. Looking at the chart above, XBI's low point in its 52 week range is $100. In addition to holding 155 positions, its top 10 holdings make up just 14. 1% over the past year to close the last trading session at $81. Holdings. The top holding in XBI receives just a 1. To make the peptide traceable, it was radiolabeled with the long. S. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. XBI has lost 27. The next columns indicate the amount of XBI stock held by each of the funds holding XBI, followed by the XBI position size held by the fund, and lastly the date of the quarterly filing period the data represents. Region Percentage; North, Central and South America: 99. 45% vs 0. The best stock comparison tool in Galaxy! Pick any two stocks and find out how much money each would've made you had you purchased them at the same time. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. 81 and $97. Track SPDR Biotech ETF (XBI) Stock Price, Quote, latest community messages, chart, news and other stock related information. Find the latest quotes for SPDR S&P Biotech ETF (XBI) as well as ETF details, charts and news at Nasdaq. 54%. 3. The company’s fifty day. Sign Up Log In Dashboard LogoutLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. SPDR S&P BIOTECH ETF 87. View complete WCLD exchange traded fund holdings for better informed ETF trading. 00 (0. 84. A comparison between ARKG and XBI based on their expense ratio, growth, holdings and how well they match their benchmark performance. 12% in the last one year (as. S. 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. Across the 192 current stocks in the fund, all holdings have a weighting between 0. ("Boron One" or the. SPDR® S&P Biotech ETF (XBI) Stock Price, Quote, News & Analysis Save 45%! Get early access to our annual Black Friday Sale » XBI SPDR® S&P Biotech ETF. 35% ; Sectors:. 1. NEW: Experience our best charts yet. 04%. 01%). Front end load. 5% year-to-date and 38. Over a longer time than that, it has no top holdings. Site search Search. 79 in February 2021 and has fallen over (50%) to $76. Below is the comparison between BBC and XBI. 57 billion. 64% for the trailing three-year period, making it a high risk. Free ratings, analyses, holdings, benchmarks, quotes, and news. The top 10 concentration is much higher than XBI at 38% given it only has 30 holdings compared to XBI's 140+ holdings. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. Unlock comprehensive insights, track historical transformations, and employ powerful tools for comparison and categorization, propelling you to stay ahead in your investment strategies. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). IBB outperformed the S&P 500 last year and did much better than XBI. Trader's Guide 2024 Ships December 21st. $0. $0. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. XBI has traded between $64. 9%. com. Complete SPDR S&P Biotech ETF funds overview by Barron's. 44 per share, with $92. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Both XBI and XLV are ETFs. 1005 Broad St 5 Victoria BC V8W 2A1. 00%) Most Recent Dividend 0. There are a number of factors behind this strategy, the overriding one being that biotech has pulled back in the fall a large percentage of the. The Global X Genomics & Biotechnology ETF (GNOM) seeks to invest in companies that potentially stand to benefit from further advances in the field of genomic science, such as companies involved in gene editing, genomic sequencing, genetic medicine/therapy, computational genomics, and biotechnology. 2% weight, and there are 133 holdings in total in the fund (Figure 1). 50 down to $98. $156. IBB has a higher expense ratio than XBI (0. 12% in the last one year (as. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. XBI's 120. 78% of XBI's total assets under management. Immunovant Inc. Assets Under Management. 9. As of 9/30/23. Only one of these, AbbVie, is a. Both BBC and XBI are ETFs. The current portfolio value is calculated to be $6. 01 to $0. 15%: Country Percentage; United States: 94. 2013. Warren Buffett is known for holding onto his S&P 500 stocks forever. 1. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments. Year-to-date, the SPDR S&P Biotech ETF has lost about -15. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. 4% of the stocks in our database. Asset type. 40 for Nov. The Fund's prospectus and statement of additional information dated October 31, 2015, are incorporated by reference into this. The fee is slightly higher for SBIO - . Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. View Holdings As of 08/31/2023. According to data from U. Dividend Yield. ETF Constituents for S&P Biotech SPDR (XBI) provide detail on the individual stock holdings that make up the ETF. Consumer Staples Select Sector SPDR ETF ETF holdings by MarketWatch. 81 and $134. In addition to holding 155 positions, its top 10. 60 as the 52 week high point — that compares with a last trade of $77. ETF Channel Staff - Friday, October 20, 6:48 AM. VHT has a higher 5-year return than XBI (7. 51. Viehbacher reported, “In the second quarter, Biogen continued to advance groundbreaking science with the FDA approval of two first-in-class therapies for Alzheimer’s disease and ALS, while also delivering on our. XBI's top 10 holdings account for about 11. 97. SBIO holds 79 companies vs. Chart. 37% in the last one. 71% of total assets under management. 2014. 81% and is down about -5. In addition, the recent spike in volatility has increased option prices even. The XBI underweights large cap biotechs and its top holdings include volatile smaller caps at about 1-2%. 96%, and is down about -5. Discover historical prices for XBI stock on Yahoo Finance. There is no guarantee the fund will achieve its stated investment objective. 15 billion. The Health category average is 45. Again, top 10 holdings. Snapshot: XBI. XBI ETF's holdings offer significant diversification. Both VHT and XBI are ETFs. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. With XBI trading at a recent price near $131. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF. XBI. 5. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style,. The first column indicates the name of each of the funds holding XBI, with a link to that fund's top holdings. 2. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. 60 as the 52 week high point — that compares with a last trade of $70. 9% vs -5. The XBI holdings are quite variable probably helped by algos. 52 (-1. BlackRock Files for Spot Ethereum ETF. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. View Top Holdings and Key Holding Information for Direxion Daily S&P Biotech Bull 3X Shares (LABU). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 08%. XBI's top 10 holdings account for about 14. 13%) Gold 1,980. 12% over the last 12 months (as of 07/18/2023). Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Analyst Forecast. 81. IBB has 8. SPDR S&P Biotech ETF is a equity fund issued by SSgA. Oct 10, 2022 01:14PM EDT. For XBI holdings in the human health space, I think you also have to account for regulatory and policy risk tied to reimbursement rates for expensive drugs. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. SPDR S&P Biotech ETF ETF holdings by MarketWatch. XBI currently has 133 holdings. 09% of its total assets under management. 003 on 06/20/23 ; Management Fee 0. Nearly half of its holdings are early-stage players with no drug on the market yet and that therefore. 9%: Israel: 3. 7% of assets. No company usually makes up more than two percent of. Meanwhile, XBI equal weights its holdings. 37% in the last one. 4; Top 10 Holdings % Portfolio Weight Market Value USD 2014. This is based on the percent of the fund this stock's assets represent. As a result, the ETF reached a new 8-month low. As of Oct 31 2023. 08%. 01%). , Biogen Inc. Holdings; Holdings Overlap; Attribution; Fundamental Chart; Scatter Plot; Tech Chart; Stress Test; ESG; Data; More. 22% of total assets) As of November 16, 2023. View Holdings As of 09/30/2023. -listed equities in the biotechnology sector. View daily, weekly or monthly formats back to when SPDR S&P Biotech ETF stock was issued. The Global X Nasdaq 100 Covered Call ETF (QYLD) follows a “covered call” or “buy-write” strategy, in which the Fund buys the stocks in the Nasdaq 100 Index and “writes” or “sells” corresponding call options on the same index. 26 during this last 52-week period. Notable ETF Outflow Detected - XBI, CYTK, CCXI, SRPT. 53 (+3. XBI focuses on health care investments and follows the S&P Biotech Index. Performance and Risk The ETF has lost about -29. Looking at the chart above, XBI's low point in its 52 week range is $62. Performance. Better trading starts here. XBI has an overall POWR Rating of D, equating to a Sell. 08 per unit, that means that analysts see 59. The top ten holdings have a 48. by Morningstar Manager Research. Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006. Shares of Amgen , IBB's top holding with a weight of 8. The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U. The sale of ETFs is subject to an activity assessment fee (from $0. The weighted harmonic average of closing market price divided by. Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target. 70% so far this year and is down about -16. Krane Carbon Cfc (138001) 18. 10 as of November 2, 2022. XBI is lower by 45% over the past two years, while the S&P 500 ETF (SPY Quick Quote SPY - Free Report) is higher by 8. 40. Looking at the chart above, XBI's low point in its 52 week range is $72. At midday the XBI is rebounding indicating there is buying interest near $101. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. Taking a look at the XBI, it peaked at $174. 250-391-1110. XBI holdings. Looking at the chart above, XBI's low point in its 52 week range is $115. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Market Capitalization. The next columns indicate the amount of XBI stock held by each of the institutional holders of XBI, followed by the XBI position size held by the institution, and finally the. As can be seen, XBI holds some of the most innovative small-cap biotech companies at equal weight (almost). As of Oct 31 2023. Holdings: 136: Inception Date: Jan 31, 2006: About XBI Fund Home Page The SPDR S&P BIOTECH ETF (XBI) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The famed investor's Berkshire Hathaway (. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. 17% for the trailing three-year period, which makes XBI a high. 60 as the 52 week high point — that compares with a last trade of $77. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. The XBI has been a leader beating other ETFs YTD, up about 35% until today. 96 on December 31, 2021, to $83 per share at the end of 2022. Holdings. 35%). S. 13 and $94. Further, the fund owns $6. 53 (+3. 35%). $6. 66% so far this year and in the past. The ETF has lost about -22. Aug 4, 2021 10:47AM EDT. A lot of these companies can't survive unless someone with deep pockets is willing to pay boatloads of money for the treatments/cures they're developing. Please call us for more information - (250). 38%. 98 and standard deviation of 37. The ETF has lost about -30. 15%: Holdings Analysis. XBI holdings. Many holdings in XBI are cash positive, and the fund itself is cash positive and earning positive too. A list of holdings for XBI (SPDR S&P BIOTECH ETF) with details about each stock and its percentage weighting in the ETF. 96%, and is down about -5. I have thoroughly reviewed the holdings of the XBI and have come away impressed with how broad-based the composition of the ETF is. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. 2. 15 billion. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). View complete IBB exchange traded fund holdings for. News & World Report, XBI enjoys volume of 20. Looking at the chart above, XBI's low point in its 52 week range is $63. com. 75M), Brown Advisory. 78%) has been the biggest winner, with its shares jumping nearly 40% year to date. Figure 1 - XBI ETF top 10 holdings (ssga. 5%, and a 2. The. Looking at the chart above, XBI's low point in its 52 week range is $68. XBI vs ARKG. Performance and Risk. Seeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocks. SPDR S&P BIOTECH ETF. 44 per share, with $92. 38%. 06 as the 52 week high point — that compares with a last trade of $109. 2, 2023. This major support zone runs from $101. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. US. 28% so far this year and in the past one. 60 as the 52 week high point — that compares with a last trade of $69. Up vote for PJP but it is pharmaceutical focused and technically not as broad as other biotech ETF's, though the top 10 holdings are comparable. 12 and $91. Stocks. XBI: SPDR S&P Biotech ETF - Fund Holdings. In contrast, most. 12% in the. Single Cell Genomics Workflow Automation Cell Analytics Lab Equipment Spatial Genomics Lab Equipment.